Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Hironori Yashima"'
Autor:
Yusaku Mori, Makoto Ohara, Michishige Terasaki, Naoya Osaka, Hironori Yashima, Tomomi Saito, Yurie Otoyama-Kataoka, Takemasa Omachi, Yuichiro Higashimoto, Takanori Matsui, Tomoyasu Fukui, Sho-ichi Yamagishi
Publikováno v:
Biomedicines, Vol 11, Iss 12, p 3112 (2023)
We have developed DNA aptamers that can inhibit the toxic effects of advanced glycation end products (AGE-Apts). We herein evaluated the effects of AGE-Apts on muscle mass and strength in senescence-accelerated mouse prone 8 (SAMP8) mice. Eight-month
Externí odkaz:
https://doaj.org/article/2702c5b64a744305b3a937b78da3457c
Autor:
Naoya Osaka, Yusaku Mori, Michishige Terasaki, Munenori Hiromura, Tomomi Saito, Hironori Yashima, Yoshie Shiraga, Raichi Kawakami, Makoto Ohara, Tomoyasu Fukui, Sho-ichi Yamagishi
Publikováno v:
Journal of International Medical Research, Vol 50 (2022)
Objective Sodium-glucose cotransporter-2 (SGLT2) inhibitors exhibit cardioprotective properties in patients with diabetes. However, SGLT2 is not expressed in the heart, and the underlying molecular mechanisms are not fully understood. We investigated
Externí odkaz:
https://doaj.org/article/70384bedcd3a41af9453288197520c36
Autor:
Michishige Terasaki, Hironori Yashima, Yusaku Mori, Tomomi Saito, Yoshie Shiraga, Raichi Kawakami, Makoto Ohara, Tomoyasu Fukui, Tsutomu Hirano, Yuichiro Yamada, Yutaka Seino, Sho-ichi Yamagishi
Publikováno v:
Biomedicines, Vol 9, Iss 7, p 832 (2021)
Glucose-dependent insulinotropic polypeptide (GIP) has been reported to have an atheroprotective property in animal models. However, the effect of GIP on macrophage foam cell formation, a crucial step of atherosclerosis, remains largely unknown. We i
Externí odkaz:
https://doaj.org/article/a05162f7f8d34e2680a4617c06428ef7
Autor:
Michishige Terasaki, Munenori Hiromura, Yusaku Mori, Kyoko Kohashi, Hideki Kushima, Masakazu Koshibu, Tomomi Saito, Hironori Yashima, Takuya Watanabe, Tsutomu Hirano
Publikováno v:
International Journal of Endocrinology, Vol 2018 (2018)
Dipeptidyl peptidase-4 (DPP-4) inhibitors could have antiatherosclerotic action, in addition to antihyperglycemic roles. Because macrophage foam cells are key components of atherosclerosis, we investigated the effect of the DPP-4 inhibitor teneliglip
Externí odkaz:
https://doaj.org/article/c03cfec54da349afb7f57ce727a311c3
Publikováno v:
Clinical Case Reports, Vol 7, Iss 3, Pp 585-586 (2019)
Key Clinical Message We report a rare but fatal case of emphysematous cystitis (EC) that presented as a typical image of gas bubbles within the urinary bladder wall on computed tomography (CT). This disease has a high mortality rate more than that re
Externí odkaz:
https://doaj.org/article/19f0ccd280a04f4b9e6d15a2bc430b5f
Autor:
Tomoki Fujikawa, Tsutomu Hirano, Takanori Matsui, Naoya Osaka, Ayako Fukase, Nobuko Sato, Tomoyasu Fukui, Hironori Yashima, Yasuyoshi Takahashi, Hideki Kushima, Munenori Hiromura, Sho-ichi Yamagishi, Michishige Terasaki, Yusaku Mori, Hiroe Nagaike, Makoto Ohara, Yo Kohata, Kyoko Shinmura
Publikováno v:
Diabetes Therapy
Introduction Pigment epithelium-derived factor (PEDF) may play a role in cardiometabolic disorders. The aim of this study was to investigate which biochemical and clinical parameters are independently associated with serum PEDF levels in patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7da00fa5bd3dbfe00948210f97aac2d
https://doi.org/10.1007/s13300-021-01008-y
https://doi.org/10.1007/s13300-021-01008-y
Autor:
Munenori Hiromura, Yusaku Mori, Michishige Terasaki, Hideki Kushima, Tomomi Saito, Naoya Osaka, Hironori Yashima, Makoto Ohara, Tomoyasu Fukui, Takanori Matsui, Sho-ichi Yamagishi
Publikováno v:
Diabetes & Vascular Disease Research
Diabetic cardiomyopathy is associated with an increased risk for heart failure and death in patients with diabetes. We investigated here whether and how GIP attenuated cardiac hypertrophy and fibrosis in diabetic mice with obesity. Diabetic db/db mic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d64792195ea58021ef3cb713dd1e545
http://europepmc.org/articles/PMC8755933
http://europepmc.org/articles/PMC8755933
Autor:
Michishige Terasaki, Yusaku Mori, Hironori Yashima, Tomomi Saito, Ami Sotokawauchi, Takanori Matsui, Munenori Hiromura, Naoya Osaka, Ayako Fukase, Raichi Kawakami, Yoshie Shiraga, Makoto Ohara, Tomoyasu Fukui, Shoichi Yamagishi
Publikováno v:
Journal of Hypertension. 41:e272
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89ad77a1f82b9fb03a7ddc1cc936238d
https://doi.org/10.1097/01.hjh.0000915504.77318.65
https://doi.org/10.1097/01.hjh.0000915504.77318.65
Autor:
Yoshie Shiraga, Yusaku Mori, Makoto Ohara, Sho-ichi Yamagishi, Yutaka Seino, Hironori Yashima, Yuichiro Yamada, Tomoyasu Fukui, Tomomi Saito, Raichi Kawakami, Michishige Terasaki, Tsutomu Hirano
Publikováno v:
Biomedicines
Volume 9
Issue 7
Biomedicines, Vol 9, Iss 832, p 832 (2021)
Volume 9
Issue 7
Biomedicines, Vol 9, Iss 832, p 832 (2021)
Glucose-dependent insulinotropic polypeptide (GIP) has been reported to have an atheroprotective property in animal models. However, the effect of GIP on macrophage foam cell formation, a crucial step of atherosclerosis, remains largely unknown. We i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7c9f8c55286c34e3a70eeda4f38a509
Autor:
Hironori Yashima
Publikováno v:
Diabetes Frontier Online. 8:002-002
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9a5c30a7edea950ac31a6015ee286ec
https://doi.org/10.15634/j0100_0801_002
https://doi.org/10.15634/j0100_0801_002